Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Argus Investors Counsel Inc.

Argus Investors Counsel Inc. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,151 shares of the medical equipment provider’s stock after selling 31 shares during the quarter. Intuitive Surgical comprises 1.3% of Argus Investors Counsel Inc.’s portfolio, making the stock its 23rd largest position. Argus Investors Counsel Inc.’s holdings in Intuitive Surgical were worth $2,039,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Creekmur Asset Management LLC grew its holdings in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new position in Intuitive Surgical in the 2nd quarter worth approximately $26,000. Delos Wealth Advisors LLC grew its holdings in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares in the last quarter. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. Finally, LRI Investments LLC bought a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ISRG shares. Wells Fargo & Company increased their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday. Barclays increased their price target on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Morgan Stanley raised their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Finally, BTIG Research set a $535.00 price objective on Intuitive Surgical in a research note on Friday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $513.74.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,655,048.26. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,902 shares of company stock worth $23,596,360. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $2.82 during midday trading on Tuesday, hitting $516.04. 347,935 shares of the stock were exchanged, compared to its average volume of 1,472,208. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $523.34. The business’s fifty day simple moving average is $484.91 and its two-hundred day simple moving average is $439.55. The company has a market capitalization of $183.04 billion, a PE ratio of 93.66, a P/E/G ratio of 5.40 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.